Company intelligence / Profile preview

PearlsInMires

Ownership: Private
Development stage: Other

Overview

PearlsInMires conducts systematic R&D for new drug candidates with a focus on oncology. The company collaborates with major research institutes, CROs, and university hospitals to develop key items and secure high-quality clinical data across all phases of development. It also partners globally for technology transfer of its main assets.

Therapeutic areas: Oncology
Modalities: Small moleculeBiologic
Industry: Biotech

Drug pipeline

7 assets

Pearl-101

Preclinical

6 more assets in the full pipeline.

Request access →

Partnerships

Collaborates with major national research institutesCROsleading university hospitalspartners with a global business development company based in the United States for technology transferconnects with global pharmaceutical companies through open innovation programs

Beyond the preview

Go deeper on PearlsInMires.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PearlsInMires.

Explore the full profile